Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies
I Lilienthal, N Herold - International journal of molecular sciences, 2020 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumour in children and
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
adolescents. Due to micrometastatic spread, radical surgery alone rarely results in cure …
Recent insights into therapy resistance in osteosarcoma
ZD Prudowsky, JT Yustein - Cancers, 2020 - mdpi.com
Simple Summary Osteosarcoma is the most common cancer of the bone for children and
adolescents. Although chemotherapy regimens have been widely available and effective for …
adolescents. Although chemotherapy regimens have been widely available and effective for …
Mechanisms of resistance to conventional therapies for osteosarcoma
L Marchandet, M Lallier, C Charrier, M Baud'huin… - Cancers, 2021 - mdpi.com
Simple Summary Osteosarcoma (OS), the most common primary bone tumor, mainly affects
children and adolescents. Unfortunately, in some cases, the absence of response to …
children and adolescents. Unfortunately, in some cases, the absence of response to …
Therapy for osteosarcoma: where do we go from here?
AJ Chou, DS Geller, R Gorlick - Pediatric Drugs, 2008 - Springer
Osteosarcoma is the most common malignant primary bone tumor in children and
adolescents. Current optimal treatment for osteosarcoma consists of multi-agent …
adolescents. Current optimal treatment for osteosarcoma consists of multi-agent …
Targeted therapy for osteosarcoma: a review
S Li, H Zhang, J Liu, G Shang - Journal of Cancer Research and Clinical …, 2023 - Springer
Background Osteosarcoma is a common primary malignant tumour of the bone that usually
occurs in children and adolescents. It is characterised by difficult treatment, recurrence and …
occurs in children and adolescents. It is characterised by difficult treatment, recurrence and …
Pathogenesis and current treatment of osteosarcoma: perspectives for future therapies
R Rathore, BA Van Tine - Journal of clinical medicine, 2021 - mdpi.com
Osteosarcoma is the most common primary malignant bone tumor in children and young
adults. The standard-of-care curative treatment for osteosarcoma utilizes doxorubicin …
adults. The standard-of-care curative treatment for osteosarcoma utilizes doxorubicin …
Chemotherapy resistance in osteosarcoma: current challenges and future directions
AJ Chou, R Gorlick - Expert review of anticancer therapy, 2006 - Taylor & Francis
For patients with osteosarcoma, the use of chemotherapy has improved survival from 11%
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …
with surgical resection alone in the 1960s, to 70% by the mid-1980s. However, survival has …
Present advances and future perspectives of molecular targeted therapy for osteosarcoma
Osteosarcoma (OS) is a bone cancer mostly occurring in pediatric population. Current
treatment regime of surgery and intensive chemotherapy could cure about 60%–75 …
treatment regime of surgery and intensive chemotherapy could cure about 60%–75 …
Novel insights and therapeutic interventions for pediatric osteosarcoma
L Kager, G Tamamyan, S Bielack - Future Oncology, 2017 - Future Medicine
High-grade osteosarcomas are the most common primary malignant tumors of bone. With
complete surgical resection and multi-agent chemotherapy up to 70% of patients with high …
complete surgical resection and multi-agent chemotherapy up to 70% of patients with high …
Origin and therapies of osteosarcoma
B Moukengue, M Lallier, L Marchandet, M Baud'huin… - Cancers, 2022 - mdpi.com
Simple Summary Osteosarcoma is the most common malignant bone tumor in children, with
a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the …
a 5-year survival rate ranging from 70% to 20% depending on the aggressiveness of the …